Dihydrolycorine Attenuates Cardiac Fibrosis and Dysfunction by Downregulating Runx1 following Myocardial Infarction

In spite of early interventions to treat acute myocardial infarction (MI), the occurrence of adverse cardiac remodeling following heart failure due to acute MI remains a clinical challenge. Thus, there is an increasing demand for the development of novel therapeutic agents capable of inhibiting the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Tingjuan, Huang, Xingxiao, Pan, Sunlei, Lu, Zhongqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557049/
https://www.ncbi.nlm.nih.gov/pubmed/34725565
http://dx.doi.org/10.1155/2021/8528239

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557049/
https://www.ncbi.nlm.nih.gov/pubmed/34725565
http://dx.doi.org/10.1155/2021/8528239

Ejemplares similares